Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Bloedow

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Pharmacokinetics and Biopharmaceutics|August 11, 1991
A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorptionC Hartmann, D C Bloedow, D G Dienhart, et al.
The American Journal of Cardiology|February 18, 1982
Pharmacokinetics of diltiazem in selected animal species and human beingsR W Piepho, D C Bloedow, J P Lacz, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 1, 1992
Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defenseP Birrer, N G McElvaney, A Gillissen, et al.
Kidney International|April 1, 1996
Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failureR Rabkin, F C Fervenza, H Maidment, et al.
The American Review of Respiratory Disease|September 1, 1991
Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysisL S Greos, P Vichyanond, D C Bloedow, et al.
The Journal of Clinical Investigation|May 1, 1994
Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized ratsR B Kimble, J L Vannice, D C Bloedow, et al.
Critical Care Medicine|January 1, 1994
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trialC J Fisher, G J Slotman, S M Opal, et al.
Cytokine|September 1, 1992
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humansE V Granowitz, R Porat, J W Mier, et al.
Cancer Research|November 1, 1990
Imaging of non-small cell lung cancers with a monoclonal antibody, KC-4G3, which recognizes a human milk fat globule antigenD G Dienhart, R F Schmelter, J L Lear, et al.
Radiology|May 1, 1991
Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody columnJ L Lear, R K Kasliwal, A J Feyerabend, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Pharmacokinetics and Biopharmaceutics|August 11, 1991
A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorptionC Hartmann, D C Bloedow, D G Dienhart, et al.
The American Journal of Cardiology|February 18, 1982
Pharmacokinetics of diltiazem in selected animal species and human beingsR W Piepho, D C Bloedow, J P Lacz, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 1, 1992
Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defenseP Birrer, N G McElvaney, A Gillissen, et al.
Kidney International|April 1, 1996
Pharmacokinetics of insulin-like growth factor-1 in advanced chronic renal failureR Rabkin, F C Fervenza, H Maidment, et al.
The American Review of Respiratory Disease|September 1, 1991
Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysisL S Greos, P Vichyanond, D C Bloedow, et al.
The Journal of Clinical Investigation|May 1, 1994
Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized ratsR B Kimble, J L Vannice, D C Bloedow, et al.
Critical Care Medicine|January 1, 1994
Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trialC J Fisher, G J Slotman, S M Opal, et al.
Cytokine|September 1, 1992
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humansE V Granowitz, R Porat, J W Mier, et al.
Cancer Research|November 1, 1990
Imaging of non-small cell lung cancers with a monoclonal antibody, KC-4G3, which recognizes a human milk fat globule antigenD G Dienhart, R F Schmelter, J L Lear, et al.
Radiology|May 1, 1991
Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody columnJ L Lear, R K Kasliwal, A J Feyerabend, et al.
Pageof 4